We are live on ! Find out more
CLP

Charis Legacy Partners Portfolio holdings

AUM $81.3M
1-Year Est. Return 30.13%
This Fund
S&P 500
This Quarter Est. Return
+2.32%
1 Year Est. Return
+30.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$67.8M
AUM Growth
+$728K
Cap. Flow
-$755K
Cap. Flow %
-1.11%
Top 10 Hldgs %
83.95%
Holding
31
New
2
Increased
7
Reduced
12
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 4.84%
2 Industrials 1.41%
3 Communication Services 0.34%
4 Financials 0.33%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
26
Berkshire Hathaway Class B
BRK.B
$1.11T
$223K 0.33%
443
-86
-16% -$42.8K
ABBV icon
27
AbbVie
ABBV
$444B
-2,108
Closed -$488K
AMZN icon
28
Amazon
AMZN
$2.92T
-941
Closed -$207K
IJR icon
29
iShares Core S&P Small-Cap ETF
IJR
$110B
-1,945
Closed -$231K
VB icon
30
Vanguard Morningstar Small-Cap ETF
VB
$79.7B
-1,549
Closed -$394K
VSS icon
31
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
-2,366
Closed -$337K

Similar funds

Charis Legacy Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Charis Legacy Partners held 31 positions worth $67.8M, up 1.1% from $67M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Charis Legacy Partners's Q4 2025 filing shows 2 new, 7 increased, 12 reduced and 5 closed positions. Its largest new stake was iShares Select Dividend ETF: 1,871 shares worth $264K. The largest sale was AbbVie, an estimated $488K.

By sector, the portfolio is most concentrated in Technology at 4.8% of assets, down from 4.9% a quarter earlier, followed by Industrials and Communication Services.

  • Charis Legacy Partners's largest Q4 2025 buy was iShares Select Dividend ETF: 1,871 shares worth $264K.
  • Charis Legacy Partners added most to Vanguard Total International Stock ETF in Q4 2025, an estimated $573K increase.
  • Charis Legacy Partners's biggest Q4 2025 reduction was Vanguard Morningstar Value ETF, cutting an estimated $281K.
  • Charis Legacy Partners fully exited AbbVie in Q4 2025, selling an estimated $488K.
  • Charis Legacy Partners's ten largest holdings make up 84% of its $67.8M portfolio in Q4 2025.
  • Charis Legacy Partners opened 2 new positions and closed 5 in Q4 2025.
  • Charis Legacy Partners's portfolio value rose 1.1% quarter-over-quarter to $67.8M.

Based on Charis Legacy Partners's 13F filing for Q4 2025, filed 8 Jan 2026.